Experientia

, Volume 33, Issue 7, pp 905–906 | Cite as

Combined action of ribovirin and rimantadine in experimental myxovirus infection

  • G. A. Galegov
  • N. L. Pushkarskaya
  • N. P. Obrosova-Serova
  • V. M. Zhdanov
Specialia Biologica

Summary

This communication presents the results of the comparative study of the chemotherapeutic activity of ribovirin (virazol) and rimantadine and their combined action on the experimental influenza infection in tissue culture and in vivo.

Keywords

Influenza Tissue Culture Virazol Combine Action Influenza Infection 

References

  1. 1.
    A. Tsunoda, H. F. Maassab, K. W. Cochran and W. C. Eneland, Antimicrob. Drug Chemotherap., 553 (1965).Google Scholar
  2. 2.
    R. W. Sidwell, J. H. Huffman, L. B. Allen, J. T. Witkowsky and R. K. Robins, Science177, 705 (1972).PubMedGoogle Scholar
  3. 3.
    J. T. Witkowsky, R. K. Robins, G. P. Khare and R. W. Sidwell, J. Med. Chem.15, 1150 (1972).CrossRefPubMedGoogle Scholar
  4. 4.
    D. S. Streeter, J. T. Witkowsky, G. P. Khare, R. W. Sidwell, R. J. Bauer, R. K. Robins and L. N. Simon, Proc. nat. Acad. Sci. USA70, 1174 (1973).PubMedGoogle Scholar
  5. 5.
    G. A. Galegov, S. V. Lavrov and N. L. Pushkarskaya, Lancet,II, 1086 (1967).CrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag 1977

Authors and Affiliations

  • G. A. Galegov
    • 1
  • N. L. Pushkarskaya
    • 1
  • N. P. Obrosova-Serova
    • 1
  • V. M. Zhdanov
    • 1
  1. 1.The D. I. Ivanovsky Institute of VirologyMoscowUSSR

Personalised recommendations